Luisa Di Stefano received her PhD in life science in 2004 from the European Institute of Oncology in Milan (Italy), where she identified and characterized novel members of the E2F family of transcription factors. As part of her postdoctoral work at the Massachusetts General Hospital Cancer Center and Harvard Medical School in Boston (USA), she studied the role of the histone demethylase dLsd1 in vivo in Drosophila. She is currently a group leader at the Center for Integrative Biology in Toulouse (France). Her research is focused on the role of chromatin in transposable element silencing.